RT Journal Article
SR Electronic
T1 ▼Paclitaxel for ovarian cancer
JF Drug and Therapeutics Bulletin
JO Drug Ther Bull
FD BMJ Publishing Group Ltd
SP 41
OP 42
DO 10.1136/dtb.1994.32641
VO 32
IS 6
YR 1994
UL http://dtb.bmj.com/content/32/6/41.abstract
AB Relevant BNF section: 8.1.5Paclitaxel (Taxol - Bristol-Myers Squibb) is the first of a new group of cytotoxic drugs, the taxanes. It is licensed for the treatment of patients with metastatic ovarian carcinoma "where standard, platinum-containing, therapy has failed". What is its place in treatment?